HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Unpublished clinical trial results a ‘violation of the covenant’ with participants Jennifer Byrne
• Is the FDA’s guidance on FDAAA 810 adequate to ensure compliance?
• Out of the dark age Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
• Educating APPs to provide primary palliative care improves integration into practice Denice Economou, PhD, CNS, CHPN
• So, you want to be a mentor? Nicholas J. Petrelli, MD, FACS
• Combating a killer: How to identify, address loneliness among patients with cancer Matthew J. Loscalzo, LCSW, FAPOS
• USPSTF expands colorectal cancer screening recommendation to include adults aged 45 years John DeRosier
• Looking for 'a seat at the table': Study evaluates ageism in cancer clinical trials Jennifer Byrne
• Cord blood may be effective for treatment of 20 pediatric disorders Jennifer Byrne
• Research links inflammatory proteins with COVID-19 severity Jennifer R. Southall
• Overuse of antibiotics may shorten survival in urothelial carcinoma Jennifer Byrne
• Virtual visits, masks, social distancing complicate patient/oncologist connections Jennifer Byrne
• Trial to test acalabrutinib for patients with blood cancer, COVID-19 Jennifer Byrne
• Number of U.S. radiotherapy facilities rises, but many Americans still lack close access Jennifer R. Southall
• Image-guided IMRT associated with fewer gastrointestinal adverse events in cervical cancer Jennifer R. Southall
• PET molecular imaging helps guide treatment, improves DFS in recurrent prostate cancer Jennifer R. Southall
• Single-fraction SBRT ‘a one-stop, knockout punch’ for oligometastatic lung tumors Jennifer R. Southall
• Black patients with cancer may face higher risk for hospitalization due to COVID-19 John DeRosier
• Substantial racial disparities observed in use of telehealth by patients with cancer John DeRosier
• Study shows disparities in access to molecular diagnostics for colorectal cancer Jennifer R. Southall
• Sequencing trial shows ‘interesting trend’ with ‘sandwich’ approach to melanoma treatment Alexandra (Sasha) Todak
• Sotorasib shows anticancer activity in KRAS G12C-mutated NSCLC John DeRosier
• Eltrombopag regimen improves response rates as initial therapy for severe aplastic anemia Jennifer R. Southall
• Summer program for high school students targets gender disparities in oncology Jennifer R. Southall
• Total body irradiation linked to long-term breast cancer risk Jennifer R. Southall
• Standalone D-dimer, compression ultrasonography a safe strategy to diagnose DVT John DeRosier
• Many men ‘can safely be spared’ adjuvant radiotherapy after prostatectomy, analysis shows John DeRosier
• Targeted treatments extend survival in pancreatic cancer John DeRosier
• Pregnancy after breast cancer safe for women with germline BRCA mutations John DeRosier
• High-dose cytarabine improves EFS for subset of infants with acute lymphoblastic leukemia Jennifer R. Southall
• Newly identified mutations in AML may help refine risk classification, optimize treatment Jennifer R. Southall
• Bortezomib added to standard therapy confers survival benefit in light-chain amyloidosis John DeRosier
• Postoperative hypofractionated stereotactic radiotherapy effective for brain metastases Jennifer R. Southall
• Reduced-intensity therapy effective for children with very low-risk ALL John DeRosier
• Investigational agents receive fast track designation for hematology/oncology indications
• FDA seeks more data about cell therapy for pediatric GVHD
• FDA approves Monjuvi as part of combination regimen for relapsed or refractory DLBCL
• FDA grants breakthrough therapy status to pevonedistat for myelodysplastic syndrome
• FDA approves Guardant360 CDx to identify EGFR mutations in non-small cell lung cancer
• FDA approves FoundationOne CDx test as companion diagnostic for Vitrakvi
• FDA grants full approval to venetoclax for AML
• FDA grants new indication for mepolizumab in hypereosinophilic syndrome
• FDA expands Keytruda approval for classical Hodgkin lymphoma
• Huntsman Cancer Institute makes leadership appointments
• Grants fund research into effects of healthy lifestyles on cancer prevention, survivorship
• Global Cancer Institute appoints co-chief medical officers
• Mount Sinai appoints director of gastrointestinal oncology program
• Genetics researcher to receive lecture award
• Cleveland Clinic announces several oncology staff appointments